EPISODE · Oct 30, 2024 · 21 MIN
#46 - Frank Watanabe, President & CEO at Arcutis Biotherapeutics
from BioBreakthroughs · host Slice of Healthcare LLC
Join us on the latest episode! Our Guest: Frank Watanabe, President & CEO at Arcutis Biotherapeutics.What you'll get out of this episode:Company Focus: Arcutis Biotherapeutics, under Frank Watanabe, is dedicated to treating inflammatory skin conditions, with three FDA-approved products and a fourth pending.Significant Milestones: This year, Arcutis launched two new products and partnered with a primary care company to expand its reach.Patient-Centric Approach: Arcutis prioritizes patient needs by involving dermatology practitioners and patient insights directly in decision-making.Technological Perspective: While acknowledging AI's potential in drug discovery, Arcutis is focused on tangible, current advancements without prematurely implementing AI.Expanding Accessibility: Arcutis is actively working to extend its treatments to Medicare and Medicaid markets to support a broader patient demographic.To Learn More About Our Guest And Their Company:LinkedIn https://www.linkedin.com/in/frank-watanabe-419711/ Company LinkedIn https://www.linkedin.com/company/arcutis-inc/ Website https://www.arcutis.com/ Our sponsor for this episode are:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
What this episode covers
Join us on the latest episode! Our Guest: Frank Watanabe, President & CEO at Arcutis Biotherapeutics.What you'll get out of this episode:Company Focus: Arcutis Biotherapeutics, under Frank Watanabe, is dedicated to treating inflammatory skin conditions, with three FDA-approved products and a fourth pending.Significant Milestones: This year, Arcutis launched two new products and partnered with a primary care company to expand its reach.Patient-Centric Approach: Arcutis prioritizes patient needs by involving dermatology practitioners and patient insights directly in decision-making.Technological Perspective: While acknowledging AI's potential in drug discovery, Arcutis is focused on tangible, current advancements without prematurely implementing AI.Expanding Accessibility: Arcutis is actively working to extend its treatments to Medicare and Medicaid markets to support a broader patient demographic.To Learn More About Our Guest And Their Company:LinkedIn https://www.linkedin.com/in/frank-watanabe-419711/ Company LinkedIn https://www.linkedin.com/company/arcutis-inc/ Website https://www.arcutis.com/ Our sponsor for this episode are:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
NOW PLAYING
#46 - Frank Watanabe, President & CEO at Arcutis Biotherapeutics
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.